AzTrials
AzTrials

Lateral EpicondylitisNCT03856125

Percutaneous Electrical Stimulation on Radial Nerve in Patients With Lateral Epicondylalgia

A study testing PENS plus exercise in people with Lateral Epicondylitis, run by Universidad Complutense de Madrid at 1 site in Spain.

Withdrawn

Withdrawn. The study stopped before anyone enrolled.

Official record
Search all trials

Trial summary

Lateral epicondylalgia is a common musculoskeletal condition that approximately affects 1-3% of the general population. Several authors have found greater mechanical pain sensitivity in the radial nerve when compared with healthy subjects. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Lateral Epicondylitis
What is being tested?
PENS plus exercise
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
0 participants
Where
1 siteSpain
Study dates
1 Apr 2019to 21 May 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Lateral epicondylalgia symptoms confirmed with at least 2 of the 4 following test:
  • pain during palpation of lateral epicondyle
  • pain on resisted wrist extension
  • pain on resisted middle finger extension
  • pain during hand-grip.

Who cannot join

  • History of fractures, luxations, surgery and/or musculoskeletal disorders in upper limb.
  • Neurological disorders, inflammatory and/or degenerative diseases.
  • Having received as treatment techniques that involve needles on the previous 6 months to study enrollment, or having received percutaneous electrical stimulation as a treatment before.
  • Cervical pathology, fibromyalgia, unstable cardiovascular diseases, pregnant women or under suspect of pregnancy.
  • Contraindications of needle's insertions: anticoagulant therapy, needle phobia, diabetes, hypothyroidism, lymphoedema, muscular diseases).
  • Contraindications of electrical current application.

Trial locations and contacts

1 site in 1 country.

Spain1 site
  • Universidad Complutense de Madrid

    Madrid, 28040

Other trials in Spain

About this study

Official title: Effectiveness of a Combined Treatment Percutaneous Electrical Stimulation on Radial Nerve With an Exercise Program in Patients With Lateral Epicondylalgia

Lateral epicondylalgia is a common musculoskeletal condition that approximately affects 1-3% of the general population. Several authors have found greater mechanical pain sensitivity in the radial nerve when compared with healthy subjects. Radial tunnel syndrome exhibits a similar clinical presentation to lateral epicondylalgia. Percutaneous electrical stimulation has shown reduce pain in several conditions. Percutaneous electrical stimulation on the radial nerve could cause an important relief in lateral epicondylalgia.

Hypothesis: Percutaneous electrical stimulation on radial nerve plus exercise therapy in patients with lateral epicondylalgia is better than sham percutaneous electrical stimulation plus exercise.

Read the detailed description

Randomized, double-blind, placebo controlled clinical trial, using Percutaneous Electrical Nerve Stimulation (PENS). PENS is technique to provide a transcutaneous electrical nerve stimulation current throughout needling filaments place close to the nerve.

Study Aims:

Aim #1: The primary aim of the study is to compare the effect of the immediate, short, medium and long-term of PENS on intensity of pain as measured by visual analogue scale (VAS) in patients with lateral epicondylalgia with random assignment to two treatments: PENS plus exercise program or Sham PENS plus exercise program.

Aim #2: The secondary aim of the study is to compare the effect of the immediate, short, medium and long-term of PENS on pain free grip strength, disability as measured by Patient Rated Tennis Elbow Evaluation (PRTEE) and DASH questionnaire and pressure pain threshold (PPT) and area and distribution of pain in patients with lateral epicondylalgia with random assignment to two treatments: PENS plus exercise program or Sham PENS plus exercise program, and determine if psychological factors (fear and avoidance and catastrophism) change with any of the treatments and if is related with the primary and secondary outcomes.

Being tested
PENS plus exercise, Sham PENS plus exercise
Keywords
Tennis elbow, Lateral epicondylalgia, Lateral elbow tendinopathy, Lateral elbow pain, Percutaneous electrical stimulation
Medical subject headings
Tennis Elbow

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • PENS plus exerciseOther

    The technique will be performed ultrasound-guided on the radial nerve, the places of the needle's insertions will be the following:

    • Needle will be placed at under the lateral intermuscular septum between the triceps brachii and brachialis, approximately 10cm superior to the lateral epicondyle
    • Needle will be placed at the upper third of the forearm on the posterior interosseous nerve after passing the arcade of Froshe's

    The percutaneous electrical stimulation will be realized with a transcutaneous electric nerve stimulation (TENS) current:

    • TENS Frequency - 2 Hz
    • TENS Pulse width - 250 microseconds
    • Duration - 30 minutes.
    • TENS Intensity - Increased at an intensity of visible motor response of the innervated musculature and maximal tolerable intensity.
    • Administration - One per week
  • Sham PENS plus exerciseOther

    The technique will be performed on the radial nerve, the places of the needle's. The technique will be performed ultrasound-guided on the radial nerve, the places of the needle's insertions will be the following:

    • Needle will be placed at under the lateral intermuscular septum between the triceps brachii and brachialis, approximately 10cm superior to the lateral epicondyle.
    • Needle wil be placed at the at the upper third of the forearm on the posterior interosseous nerve after passing the arcade of Froshe's.

    The current will not be working, and the needles will be placed during 30 minutes.

    • Administration - One per week
Study groups in NCT03856125
Study groupRoleWhat they receive
PENS plus exercise groupExperimental4-week intervention program with 2 weekly treatment sessions, one of percutaneous electrical stimulation and supervised exercise and the other one, domiciliary exercise.
Receives: Other: PENS plus exercise
Sham PENS plus exercise groupSham comparator4-week intervention program with 2 weekly treatment sessions, one of sham percutaneous electrical stimulation and supervised exercise and the other one, domiciliary exercise.
Receives: Other: Sham PENS plus exercise

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Pain Intensity: visual analogue scale

    Pain intensity measured with a 100mm (0 - No pain - 100 The worst pain) visual analogue scale

    Measured: Change from baseline to immediate (single session); 4 weeks; 8 weeks; 16 weeks; 28 weeks; 52 weeks

Secondary outcomes (8)
  1. Patient Rated Tennis Elbow Evaluation (PRTEE)

    It is a 15-item questionnaire designed to measure forearm pain and disability in patients with lateral epicondylitis. The PRTEE allows patients to rate their levels of tennis elbow pain and disability from 0 to 10, and consists of 2 subscales: pain and function.

    Measured: Change from baseline to 4 weeks; 8 weeks; 16 weeks; 28 weeks; 52 weeks

  2. Disabilities of the Arm, Shoulder and Hand (DASH) Questionnaire

    It includes 30 items assessing (1) degree of difficulty during the preceding week in performing several physical activities because of problems in a upper extremity (21 items), (2) severity of each of the symptoms of pain, activity-related pain, tingling, weakness, and stiffness (5 items), and (3) the problem's effect on social activities, work, and sleep and its psychological impact (4 items). Each item is answered on a 5-point scale ranging from 1 (no difficulty to perform, no symptom, or no impact) to 5 (unable to do, very severe symptom, or high impact). The responses to the 30 items are summed to form a raw score that is then converted to a scale from 0 to 100 with a formula. A higher score reflects greater disability.

    Measured: Change from baseline to 4 weeks; 8 weeks; 16 weeks; 28 weeks; 52 weeks

  3. Pain free grip strength

    Measurement the amount of force that the patient generates to the onset of pain as measured with a dynamometer

    Measured: Change from baseline to immediate (single session); 4 weeks; 8 weeks; 16 weeks; 28 weeks

  4. Pressure pain threshold using an algometer

    Measurement of pressure pain threshold in the lateral epicondyle, radial nerve in the spiral groove, C5-C6 zygapophyseal joints, and the tibialis anterior muscle.

    Measured: Change from baseline to immediate (single session); 4 weeks; 8 weeks; 16 weeks; 28 weeks; 52 weeks

  5. Area of pain

    The participants will paint the area of extension of their pain in a body chart. The area in mm^2 will be calculated using a software

    Measured: Change from baseline to 4 weeks; 8 weeks; 16 weeks; 28 weeks; 52 weeks

  6. Pain distribution

    The pain distribution will be classified as 0=no pain, 1=pain only proximal and lateral elbow, 2=distal pain to the elbow (forearm and wrist), 3= pain in other regions (arm, shoulder and neck) using the painted region in the body chart

    Measured: Change from baseline to 4 weeks; 8 weeks; 16 weeks; 28 weeks; 52 weeks

  7. Kinesiophobia

    Tampa Scale for Kinesiophobia. To assess the fear of movement and pain-related fear. The 11 items are scored 1-4, with total scores ranging from 11 to 44. The addition of all the points obtained from each of the items results in the level of kinesiophobia, with higher scores indicating greater perceived kinesiophobia

    Measured: Change from baseline to 4 weeks; 8 weeks; 16 weeks; 28 weeks; 52 weeks

  8. Pain catastrophizing

    Pain Catastrophizing Scale (PCS). This tool is a 13-item questionnaire designed to measure the three components of pain-related catastrophizing: rumination, magnification, and helplessness, resulting in a unique score. Each item is responded to on a 5-point scale (0 not at all, 4 all the time) relating the degree to which the individual experiences a thought or feeling of a painful situation.

    Measured: Change from baseline to 4 weeks; 8 weeks; 16 weeks; 28 weeks; 52 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted27 Feb 2019
  2. Study start1 Apr 2019
  3. Primary completion21 May 2020
  4. Study completion21 May 2020

Why it stopped: Covid19 locked down

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Triple blind
Who is masked
Participant, Investigator, Outcomes assessor
Enrolment
0 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03856125
Sponsor's protocol ID
CI: 19/043
Status last verified
May 2020
First submitted
20 Feb 2019
Last updated
26 May 2020
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing PENS plus exercise in people with Lateral Epicondylitis, run by Universidad Complutense de Madrid at 1 site in Spain.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: withdrawn, as of the sponsor's last update on 26 May 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was withdrawn before enrolling participants, so there are no results.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Pain Intensity: visual analogue scale (time frame: Change from baseline to immediate (single session); 4 weeks; 8 weeks; 16 weeks; 28 weeks; 52 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 May 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in